Connect with us

Business

Three Canadian airlines refusing to board 'unruly' Quebec influencers returning from Mexico – CTV News Montreal

Published

 on


Multiple Canadian airlines say they will refuse to board a group of Quebec social media influencers and reality TV stars on their way back from Cancun who were seen partying maskless, vaping, and drinking in the aisles during their departure flight last week.

Video footage of the rowdy Dec. 30 flight on board a Sunwing Airlines chartered plane circulated widely online on Tuesday and has made national headlines — and even drew some harsh words from Prime Minister Justin Trudeau.

Sunwing was the first airline to publicly say it will not let the “unruly” group of passengers board their planes after cancelling their return flight home, alleging in a statement sent to CTV News that the group “did not accept all of the terms” and conditions the airline said were necessary “to ensure the safety of the crew and passengers.”

Now, each person was left to try to book his or her own ticket home after their trip was scheduled to end on Wednesday. However, it appears that they will not have an easy time finding a flight. 

Later Wednesday morning, Air Transat followed suit and vowed to not board the people seen in the video as they try to head back home from their holiday in the popular sunset resort town of Tulum, Mexico.

Air Transat wrote on Twitter Wednesday that some members of the group tried to buy tickets with the airline, but are being denied.

The airline said “the safety of both our passengers and crew” is their “top priority.”

Hours later, Canada’s flag carrier said it was also blocking the passengers from boarding its planes.

In a statement to CTV News, Air Canada said, “With the information we currently have regarding the events that took place on the Sunwing flight, and to the extent that we can identify the passengers who were part of the group, Air Canada is denying boarding to ensure the safety of other passengers and its crew.”

‘A SLAP IN THE FACE’

The airline trouble for the passengers comes after Prime Minister Justin Trudeau condemned their behaviour on Wednesday, saying what they did on the plane was “completely irresponsible” and a “slap in the face” for those respecting public health guidelines.

The plane party is also the subject of at least two investigations — one by Sunwing and the other by Transport Canada for possible violations of Canadian Aviation Regulations, which could bring fines of up to $5,000 per violation for the passengers. 

Sunwing has said it would cooperate with the federal government in its investigation, which is also looking into non-compliance with COVID-19 measures. 

Meanwhile, some of the 150 social media celebrities stranded in Mexico say the were unfairly blamed for the plane party. One of them, Isabelle Labrecque, told her followers in an Instagram Live video that “we were sleeping” and “we don’t want to be bashed for things that we didn’t do.”

She also said “a minority” of the passengers were partying, while most were well-behaved. 

This is a developing story. More to come. 

Adblock test (Why?)



Source link

Continue Reading

Business

Markets split on BoC decision as business survey, inflation loom – BNN

Published

 on


Columnist image

The Bank of Canada is getting a pair of key indicators this week ahead of a rate decision next Wednesday that’s virtually a coin toss, as far as markets are concerned.

First up on Monday, the central bank releases its quarterly Business Outlook Survey, which provides a snapshot of how approximately 100 corporate leaders are feeling about the economy and their own business fundamentals.

When the last survey was released in October, it showed the broadest gauge of sentiment was at the highest level in the survey’s history. That was despite worsening labour shortages and as more than half of respondents (57 per cent) said they expected labour costs to accelerate over the next year.

“[Monday’s] Business Outlook Survey might have been completed too early to catch Omicron uncertainties, so expect respondents to retain a healthy dose of optimism,” said CIBC World Markets Chief Economist Avery Shenfeld in a report to clients Friday.

“The survey could show a majority expecting inflation to run above the top end of the Bank of Canada’s one-three per cent inflation band. If not for Omicron, that would spell a rate hike in January, but the uncertainties surrounding how long this disruption will last should be enough to defer that decision.”

Meanwhile, Statistics Canada will release the consumer price index for December on Wednesday. Economists are expecting to see inflation rose 4.8 per cent year-over-year in the month; that would be the fastest rate of growth since 1991.

As of 8:30 a.m. Monday morning, market data shows investors see a 59 per cent chance of a rate hike when the Bank of Canada delivers its decision on Jan. 26.

Adblock test (Why?)



Source link

Continue Reading

Business

House Price Index rose 26% in 2021, fastest pace on record – CBC News

Published

 on


The Canadian Real Estate Association’s House Price Index rose by 26.6 per cent in the 12 months up to December, the fastest annual pace of gain on record.

The group, which represents more than 100,000 realtors and tabulates sales data from homes that listed and sell via the Multiple Listings Service, said the supply of homes for sale at the end of the month hit an all-time low.

After pausing for a few weeks in the early days of the pandemic, Canada’s housing market has been on an absolute tear for the past two years, as feverish demand from buyers wishing to take advantage of rock-bottom interest rates has drastically outpaced the supply of homes to buy.

That imbalance is a major factor contributing to higher prices, as buyers have to pay more and more to outbid others because of the lack of alternatives.

Various experts are suggesting that parts of the country are showing signs of being in a speculative bubble, and CREA says the biggest reason for runaway price increases is that there aren’t enough homes being put up for sale.

“There are currently fewer properties listed for sale in Canada than at any point on record,” CREA’s chief economist Shaun Cathcart said. “So unfortunately, the housing affordability problem facing the country is likely to get worse before it gets better.”

High prices not denting demand

CREA says the average price of a Canadian home that sold on MLS in December went for $713,500. That’s actually down from the record high of more than $720,000 in November, but still well up on an annual basis.


High prices don’t seem to be slowing demand, however, as 2021 was the busiest year for home sales ever. Some 666,995 residential properties traded hands on MLS last year, smashing the previous annual record by 20 per cent.

TD Bank economist Rishi Sondhi said that there was a less than two-month supply of homes for sale during the month, which means at the current sales pace, all listings would be gone in less than two months. Under normal conditions, there’s a five-month supply of homes for sale, and Sondhi says that supply and demand imbalance is a major factor in eye-popping price gains.

“With interest-rate pull-forward behaviour keeping demand so strong, and supply struggling to keep up, it’s little wonder why prices are continuing their relentless upward march,” he said. “Buyers pulling forward demand ahead of looming interest rate hikes kept sales at unsustainable levels last month. How long this effect will last is uncertain, but it should eventually fade.”

Adblock test (Why?)



Source link

Continue Reading

Business

COVID-19 antiviral: Canada authorizes Pfizer pill – CTV News

Published

 on


OTTAWA —
Health Canada has authorized the use of Pfizer’s COVID-19 antiviral treatment Paxlovid.

The federal health agency says the prescription-only medication can be given to adults ages 18 and older to treat mild to moderate cases of COVID-19, if they have a confirmed positive viral test and are at a high risk of becoming seriously ill. 

The authorization comes with specific instructions on scenarios in which the regime cannot be used, including to prevent COVID-19 infections or to treat patients who are already hospitalized due to severe COVID-19 cases.

The medication— two antiviral medicines co-packaged together— cannot be taken for longer than five days in a row, nor can it be given to teens or children.

More details about the authorization are being provided by Health Canada’s Chief Medical Adviser Dr. Supriya Sharma, in a technical briefing in Ottawa.

Pfizer submitted clinical data for the oral medication, on Dec. 1, 2021. 

The government has a deal in place with the pharmaceutical giant securing access to an initial one million doses of the therapeutic drug.

Responding to recent calls from the provinces for a swift rollout of this medication in the face of an expected surge in Omicron hospitalizations, the federal government has vowed that delivery of the drug will happen in short order.

Health Minister Jean-Yves Duclos and Procurement Minister Filomena Tassi will be holding a press conference to discuss the rollout of this treatment at 1:30 p.m. EST.

In November 2021, Pfizer released the results of their Phase 2/3 trials for the drug, stating that they had found the pills to significantly reduce hospitalization and death in COVID-19 patients. 

Pfizer said that in a randomized, double-blind study of more than 380 patients, there was an 89 per cent reduction in the risk of being hospitalized or dying of COVID-19 in patients that received Pfizer’s pill within three days of displaying COVID-19 symptoms, compared to the study group that received a placebo.

According to Pfizer, Paxlovid is designed to block the activity of an enzyme in SARS-CoV-2 that is essential for the virus to replicate itself, and also help to slow the breakdown of the pill’s ingredients in order to help combat the virus for longer.

“PAXLOVID stops the virus from multiplying. This can help your body to overcome the virus infection and may help you get better faster,” reads Health Canada’s authorization.

Paxlovid contains two medicines co-packaged together, a 150mg pink tablet of Nirmatrelvir and a 100mg white tablet of Ritonavir, which has been used in combination with other antiviral medications before.

The regime is meant to be taken consistently twice a day, for five days in a row. The agency has outlined on their website the detailed instructions for taking this medication, as well as a list of potential contraindications.

For example, Health Canada has issued warnings for patients with kidney or liver problems; patients with a human immunodeficiency virus (HIV) infection; patients who are pregnant, breastfeeding, or are planning to become pregnant; and patients who take a series of other medicines which may interact with Paxlovid.

Side effects can include an altered sense of taste, diarrhea, muscle pain, vomiting, high blood pressure, and headache. Though, given the limited use of this medication to date, the agency cautions that it is possible not all side effects are known at this time and advise speaking with a healthcare professional if other side “troublesome” effects arise.

The medication is what is called a “protease inhibitor antiviral therapy”, a type of medication that has largely been used before to treat HIV/AIDS and hepatitis C.  

Health Canada has also been reviewing an experimental pill from drugmaker Merck, called molnupiravir, since mid August. The federal government also has a contract to purchase 500,000 of Merck’s antiviral medication, with an option for 500,000 more pending regulatory approval.

In late December, the U.S. Food and Drug Administration issued an emergency use authorization for both Pfizer and Merck’s drugs.

With files from CTV News’ Alexandra Mae Jones and Sarah Turnbull 

Adblock test (Why?)



Source link

Continue Reading

Trending